The American firm Novavax has announced its COVID-19 vaccine trial is propelling forward. Entering its third stage, what hope does this give to the UK? This final stage in the trial is key in whether the vaccine gets the green light for mass production. Recruiting up to 10,000 volunteers, aged between 18 to 84, the